INNOVATE Corp. Files 8-K, Formerly HC2 Holdings
Ticker: VATE · Form: 8-K · Filed: Oct 21, 2025 · CIK: 1006837
| Field | Detail |
|---|---|
| Company | Innovate Corp. (VATE) |
| Form Type | 8-K |
| Filed Date | Oct 21, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, corporate-actions
TL;DR
INNOVATE Corp. (fka HC2 Holdings) filed an 8-K on 10/21/25. Nothing major disclosed yet, just standard reporting.
AI Summary
On October 21, 2025, INNOVATE Corp. filed an 8-K report. The filing indicates a change in the company's reporting status and includes financial statements and exhibits. The company was formerly known as HC2 Holdings, Inc. and PTGi HOLDING, INC. prior to name changes on August 9, 2016, and April 15, 2014, respectively.
Why It Matters
This 8-K filing signals a formal update from INNOVATE Corp. to the SEC, providing transparency on its current status and any material events, which is crucial for investors monitoring the company's trajectory.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for reporting purposes and does not disclose any new material adverse information.
Key Players & Entities
- INNOVATE Corp. (company) — Registrant
- HC2 Holdings, Inc. (company) — Former company name
- PTGi HOLDING, INC. (company) — Former company name
- October 21, 2025 (date) — Date of report
- August 9, 2016 (date) — Date of name change
- April 15, 2014 (date) — Date of name change
FAQ
What is the primary purpose of this 8-K filing for INNOVATE Corp.?
The primary purpose of this 8-K filing is to report other events and to provide financial statements and exhibits as of October 21, 2025.
When was INNOVATE Corp. previously known by another name?
INNOVATE Corp. was formerly known as HC2 Holdings, Inc. and PTGi HOLDING, INC., with name changes occurring on August 9, 2016, and November 8, 2013, respectively.
What is INNOVATE Corp.'s state of incorporation and fiscal year end?
INNOVATE Corp. is incorporated in Delaware and its fiscal year ends on December 31.
What is the SEC file number and IRS Employer Identification Number for INNOVATE Corp.?
The SEC file number for INNOVATE Corp. is 001-35210, and its IRS Employer Identification Number is 54-1708481.
What is the business address of INNOVATE Corp.?
The business address of INNOVATE Corp. is 295 Madison Avenue, 12th Floor, New York, NY 10017.
Filing Stats: 507 words · 2 min read · ~2 pages · Grade level 10 · Accepted 2025-10-21 08:09:09
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share VATE New York Stock Exchange
Filing Documents
- hchc-20251021.htm (8-K) — 32KB
- a202510218-kxexhibit991.htm (EX-99.1) — 22KB
- innovateforproxya.jpg (GRAPHIC) — 17KB
- 0001006837-25-000118.txt ( ) — 248KB
- hchc-20251021.xsd (EX-101.SCH) — 3KB
- hchc-20251021_def.xml (EX-101.DEF) — 17KB
- hchc-20251021_lab.xml (EX-101.LAB) — 30KB
- hchc-20251021_pre.xml (EX-101.PRE) — 17KB
- hchc-20251021_htm.xml (XML) — 4KB
01 Other Events
Item 8.01 Other Events. On October 21, 2025, the Company issued a press release titled "MediBeacon receives regulatory approval to sell the Transdermal GFR System in China". A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K. Exhibit 99.1 shall not be deemed filed for purposes of Section 18 of the Exchange Act, nor shall it be deemed incorporated by reference in any filing under the Securities Act, except as shall be expressly set forth by specific reference in a filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release dated October 21, 2025, titled "MediBeacon receives regulatory approval to sell the Transdermal GFR System in China" 104 Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 21, 2025 INNOVATE Corp. (Registrant) By: /s/ Michael J. Sena Name: Michael J. Sena Title: Chief Financial Officer